Date | Insider | Price | Amount |
---|---|---|---|
12-14-2023 Insider Buy |
John Gregory Beattie Chief Operating Officer |
$3.12 CAGR » |
$149,836.19 47,966 shares |
12-14-2023 Insider Buy |
Michael Garrett Chief Commercial Officer |
$2.83 CAGR » |
$14,145.00 5,000 shares |
9-15-2022 Insider Buy |
Michael Garrett Chief Commercial Officer |
$23.06 CAGR » |
$23,057.70 1,000 shares |
9-9-2022 Insider Buy |
John Gregory Beattie Chief Operating Officer |
$22.34 CAGR » |
$198,826.00 8,900 shares |
3-15-2022 Insider Buy |
James Harkness Chief Operating Officer, RMS |
$19.65 CAGR » |
$765,636.60 38,968 shares |
2-22-2022 Insider Buy |
Philip A. Downing Sr. VP, Preclinical Srvcs. |
$23.97 CAGR » |
$47,945.60 2,000 shares |
2-18-2022 Insider Buy |
Michael Garrett Chief Commercial Officer |
$23.50 CAGR » |
$23,500.00 1,000 shares |
2-18-2022 Insider Buy |
Gregory Cole Davis Director |
$22.39 CAGR » |
$111,927.50 5,000 shares |
2-18-2022 Insider Buy |
Beth Taylor VP- Finance & CFO |
$23.07 CAGR » |
$115,357.50 5,000 shares |
2-18-2022 Insider Buy |
William D. Pitchford Chief HR Officer |
$21.12 CAGR » |
$73,920.00 3,500 shares |
2-18-2022 Insider Buy |
John Gregory Beattie Chief Operating Officer |
$22.71 CAGR » |
$258,871.14 11,400 shares |
2-17-2022 Insider Buy |
John E. Sagartz Chief Strategy Officer |
$19.95 CAGR » |
$49,998.71 2,506 shares |
2-17-2022 Insider Buy |
Robert Leasure Jr. President and CEO |
$23.03 CAGR » |
$115,131.00 5,000 shares |
6-7-2021 Insider Buy |
John E. Sagartz Chief Strategy Officer |
$28.70 CAGR » |
$49,995.40 1,742 shares |
5-28-2021 Insider Buy |
John E. Sagartz Chief Strategy Officer |
$24.78 CAGR » |
$49,977.36 2,017 shares |
5-13-2021 Insider Buy |
William D. Pitchford Chief HR Officer |
$23.72 CAGR » |
$35,580.00 1,500 shares |
5-13-2021 Insider Buy |
John Gregory Beattie Chief Operating Officer |
$22.91 CAGR » |
$114,550.00 5,000 shares |
5-13-2021 Insider Buy |
Beth Taylor VP- Finance & CFO |
$23.14 CAGR » |
$49,843.56 2,154 shares |
6-7-2021 Insider Buy |
John E. Sagartz Chief Strategy Officer |
$28.70 CAGR » |
$49,995.40 1,742 shares |
Also See: Institutional Holders of NOTV
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/15/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $3.14 | |
End price/share: | $4.05 | |
Dividends collected/share: | $0.00 | |
Total return: | 28.98% | |
Annualized Gain: | 80.14% | |
Starting investment: | $10,000.00 | |
Ending investment: | $12,898.00 | |
Years: | 0.36 |
NOTV Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent NOTV insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NOTV
Free NOTV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the NOTV Insider Buying occurred are:
GTLS Insider Buying |